Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives

Jordan, 1961, Pulmonary embolism, Lancet, ii, 1146, 10.1016/S0140-6736(61)91061-3

Lorentz, 1962, Parietal lesion and Enavid, Br Med J, ii, 1191, 10.1136/bmj.2.5313.1191-a

Boyce, 1963, Coronary thrombosis and Conovid, Lancet, i, 111, 10.1016/S0140-6736(63)91117-6

Stadel, 1981, Medical progress, N Engl J Med, 305, 672, 10.1056/NEJM198109173051205

Vessey, 1990, The Jephcott Lecture 1989. An overview of the benefits and risks of combined oral contraceptives

Thorogood, 1993, Oral contraceptives and cardiovascular disease, Pharmacoepidemiol Drug Safety, 2, 3, 10.1002/pds.2630020103

1995, A multinational case-control study of cardiovascular disease and steroid hormone contraceptives, J Clin Epidemiol, 48, 1513, 10.1016/0895-4356(95)00516-1

1995, Venous thromboembolic disease and combined oral contraceptives, Lancet, 346, 1575, 10.1016/S0140-6736(95)91926-0

1995, Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease, Lancet, 346, 1582, 10.1016/S0140-6736(95)91927-9

1996, Ischaemic stroke and combined oral contraceptives, Lancet, 348, 498, 10.1016/S0140-6736(95)12393-8

1996, Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives, Lancet, 348, 505, 10.1016/S0140-6736(95)12394-6

1997, Acute myocardial infarction and combined oral contraceptives, Lancet, 349, 1202, 10.1016/S0140-6736(97)02358-1

Gillmer, 1996, The pill

Vaughan, 1970, 5

1996

Maldonado, 1993, Simulation study of confounder-selection strategies, Am J Epidemiol, 138, 923, 10.1093/oxfordjournals.aje.a116813

Jick, 1995, Risk of cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components, Lancet, 346, 1589, 10.1016/S0140-6736(95)91928-7

Bloemenkamp, 1995, Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen, Lancet, 346, 1593, 10.1016/S0140-6736(95)91929-5

Spitzer, 1996, Third generation oral contraceptives and risk of venous thromboembolic disorders, Br Med J, 312, 83, 10.1136/bmj.312.7023.83

Hawkins, 1997, A comparative study of three low dose progestagens, chlormadinone acetate, megestrol acetate and norethisterone, as oral contraceptives, Br J Obstet Gynaecol, 84, 708, 10.1111/j.1471-0528.1977.tb12686.x

Hall, 1980, Blood pressure and oral progestational agents. A prospective study of 119 black women, Am J Obstet Gynecol, 136, 344, 10.1016/0002-9378(80)90860-1

Wilson, 1984, A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestagen, Br J Obstet Gynaecol, 91, 1254, 10.1111/j.1471-0528.1984.tb04747.x

Dong, 1997, Blood pressure in women using oral contraceptives, J Hypertens, 15, 1063, 10.1097/00004872-199715100-00003

Weir, 1982, Effect on blood pressure on changing from high to low dose steroid preparations in women with oral contraceptive-induced hypertension, Scott Med J, 27, 212, 10.1177/003693308202700303

1996, Reliability of data from proxy respondents in a case-control study of cardiovascular disease and oral contraceptive use, J Epidemiol Commun Health, 50, 674, 10.1136/jech.50.6.674